Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Cedric G. van der Ham"'
Autor:
Lionel Morgado, Jean-Pierre Bourquin, Mireia Camós, Hélène Cavé, Cedric G. van der Ham, Esmé Waanders, Peter M. Hoogerbrugge, Simon V. van Reijmersdal, Roland P. Kuiper, Cornelia Eckert, Željko Antić, Ad Geurts van Kessel, Beat Bornhauser, Anthony V. Moorman, Rosemary Sutton, Giovanni Cazzaniga, Frank N. van Leeuwen, Sarah Elitzur, Edwin Sonneveld, Stefan H. Lelieveld, Jiangyan Yu
Publikováno v:
PEDIATRIC BLOOD & CANCER
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Pediatric Blood & Cancer, 69, 1
Pediatric Blood & Cancer, 69
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Pediatric Blood & Cancer, 69, 1
Pediatric Blood & Cancer, 69
Contains fulltext : 248362.pdf (Publisher’s version ) (Open Access) INTRODUCTION: One-quarter of the relapses in children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) occur very early (within 18 months, before completion of treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::690060265df1e3a67d7082a530f54464
http://hdl.handle.net/10281/336865
http://hdl.handle.net/10281/336865
Autor:
Cedric G. van der Ham, Peter M. Hoogerbrugge, Željko Antić, Roland P. Kuiper, Edwin Sonneveld, Stefan H. Lelieveld
Publikováno v:
Genes, Vol 12, Iss 214, p 214 (2021)
Genes
Volume 12
Issue 2
Genes
Volume 12
Issue 2
Pediatric acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy and is characterized by clonal heterogeneity. Genomic mutations can increase proliferative potential of leukemic cells and cause treatment resistance. However, mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::418b5adb9fda63fb908d64a6f7db462f
https://www.mdpi.com/2073-4425/12/2/214
https://www.mdpi.com/2073-4425/12/2/214
